您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    我国酶免诊断试剂在输血领域应用的发展历程

    摘要

    我国输血事业从1918年上海首先报告中国人的血型开始,迄今已有100年的发展历史。为了保证输血安全,特别是防止经血传播病毒,各国已经采取了一系列措施,其中血液检测病毒标志物对保证输血安全起了重要的作用,包括乙型肝炎病毒表面抗原、丙型肝炎病毒抗体、人类免疫缺陷病毒抗体、梅毒螺旋体抗体这四项指标,这也是WHO血液筛查建议书里面明确提及的强制筛查的传染病项目。本文对我国乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒、梅毒螺旋体筛查情况进行梳理,旨在反映酶免检测试剂在我国输血领域应用的发展情况。

    <<
    >>

    Abstract

    The development of blood transfusion in China began in 1918 when Shanghai first reported the Chinese blood type,and it has been 100 years old.In order to ensure the safety of blood transfusions,in particular to prevent transmission of the virus,a series of measures have been taken among which blood screening for viral markers have played an important role in and guarantee the security of transfusion,including hepatitis B virus surface antigen,hepatitis C virus antibody,HIV antibody,and syphilis.These viral infection indicators are also mandatory infectious screening items that are explicitly mentioned in the Blood Screening Proposal of WHO.Since 1960s,blood stations around China have carried out tests for HBsAg,HCV,HIV,and TP one after another,which has led to a significant drop in the transmissible virus infection rate.In our country,Elisa reagents have been widely used as blood screening reagents in the nationwide blood collection and supply system.That have the advantages of low cost,short reaction time,simple operation,and low requirements on the environment and equipment.It played an important role in protecting China's blood safety.This article aims to provide an overview of the application history in blood stations of the four-important blood screening Elisa reagents for HIV,HBV,HCV and TP.

    <<
    >>
    作者简介
    卫良:卫良,北京万泰生物药业股份有限公司研究员,主管技师。
    <<
    >>
    相关报告